Michael Auerbach is the Founder and General Partner of Subversive Capital. See sector focus and contact routes.
Michael Auerbach is the Founder and General Partner of Subversive Capital, a New York-based venture firm where he leverages a background in strategic intelligence and prior executive roles at Albright Stonebridge Group to guide radical companies. His investment thesis targets early-stage ventures whose core missions subvert the status quo and require sophisticated government or regulatory strategies for success, with a notable focus on the global cannabis industry. While specific check sizes and lead/follow behavior are not publicly detailed, Auerbach frequently serves as a board director or lead independent director for his investments, such as at Atai Life Sciences and Tilray Brands. His portfolio includes notable companies like Atai Life Sciences, a clinical-stage biopharmaceutical firm, and Tilray Brands, a pioneering global cannabis company listed on Nasdaq. Auerbach is also an expert in the cannabis sector and a significant shareholder of Privateer Holdings, Inc., further demonstrating his deep industry involvement. He distinguishes his approach by investing in companies that challenge existing norms and often utilize ETF sponsorship as part of
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.
Investors like Michael Auerbach · Full investor directory · Investor access · Company funding database